M&A Deal Summary

ArchiMed Acquires Symbio Proinnovera

On November 17, 2023, private equity firm ArchiMed acquired life science company Symbio Proinnovera

Acquisition Highlights
  • This is ArchiMed’s 13th transaction in the Life Science sector.
  • This is ArchiMed’s 8th transaction in the United States.
  • This is ArchiMed’s 1st transaction in New York.

M&A Deal Summary
Date 2023-11-17
Target Symbio Proinnovera
Sector Life Science
Buyer(s) ArchiMed
Deal Type Buyout (LBO, MBO, MBI)

Target

Symbio Proinnovera

Jefferson, New York, United States
Symbio Proinnovera is a full-service clinical trial CRO offering for dermatology, complemented by a business active in the pre-clinical formulation of topicals, providing its client’s dermatology and aesthetics services – from pre-clinical formulation work to subsequent clinical trial execution. Symbio Proinnovera is based in Jefferson, New York.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ArchiMed

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 8.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.

DEAL STATS #
Overall 34 of 36
Sector (Life Science) 13 of 13
Type (Buyout (LBO, MBO, MBI)) 19 of 20
State (New York) 1 of 1
Country (United States) 8 of 9
Year (2023) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-10-19 Vita

Bury Saint Edmunds, United Kingdom

Vita is a provider of mental and physical health services. Vita provides a range of NHS outpatient mental health talking therapies, musculoskeletal and dermatology services, with operational hubs in London and four regional centres in Bristol, Orpington, Oldham and Leicestershire. Vita also offers outsourced physiotherapy and counselling services to the corporate and occupational health markets. Vita’s services address two of the top causes of illness in the UK. Vita treats mild to moderate mental health conditions such as anxiety and depression. Vita was founded in 1987 and is based in Bury Saint Edmunds, England.

Sell £74M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-11-27 Instem

Stone, United Kingdom

Instem is a provider of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem was founded in 1969 and is based in Stone, England.

Buy £203M
Mergr

Product

Company

Legal